Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.67 |
| ▸ | CA2 | P00918 | 4/20 | 0.67 |
| ▸ | CA12 | O43570 | 3/20 | 0.67 |
| ▸ | CA7 | P43166 | 3/20 | 0.67 |
| ▸ | CA9 | Q16790 | 3/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | MMP12 | P39900 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10046425 | 0.91 | CA12 (0.80) | CA1CA2CA12CA7CA9 | |
| SCHEMBL12485837 | 0.86 | CA1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL28414016 | 0.85 | CA12 (0.64) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5603402 | 0.81 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| SCHEMBL224031 | 0.81 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| SCHEMBL3264678 | 0.81 | CA12 (0.64) | CA1CA2CA12CA7CA9 | |
| SCHEMBL29453072 | 0.81 | ALDH1A1 (0.69) | CA1CA2CA12CA14THRB | |
| SCHEMBL337585 | 0.81 | ALDH1A1 (0.69) | CA1CA2CA12CA14THRB | |
| SCHEMBL7026198 | 0.79 | ALDH1A1 (0.59) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9418781 | 0.79 | CA12 (0.61) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8207374-B2 | Process for the synthesis of ethers of aromatic acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-26 | — | — | US | disclosed |
| US-20100016540-A1 | PROCESS FOR THE SYNTHESIS OF ETHERS OF AROMATIC ACIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-01-21 | — | — | US | disclosed |
| US-7378547-B1 | Process for the synthesis of hydroxy aromatic acids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016540-A1 | PROCESS FOR THE SYNTHESIS OF ETHERS OF AROMATIC ACIDS | DDC, TYR, AHR | CA1 3260/4885CA2 3035/4885CA12 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.